FDA Approves First Cellular Therapy to Treat Patients with Unresectable or Metastatic Melanoma

Today, the U.S. Food and Drug Administration approved Amtagvi, the first cellular therapy indicated for the treatment of adult patients with a type of skin cancer (melanoma) that is unable to be removed with surgery (unresectable) or has spread to other parts of the body (metastatic) that…#pd1 #braf #mek #petermarks #phd #fda #melanoma #nicoleverdun #acceleratedapproval #effectiveness
Source: Reuters: Health - Category: Consumer Health News Source Type: news